BEIJING SL PHARMAC financial statements, including revenue, expenses, profit, and loss

The total revenue of 002038 for the last quarter is 147.55 M CNY, and it's 2.17% higher compared to the previous quarter. The net income of Q3 24 is -46.33 M CNY.